Optimal anti-amyloid-beta therapy for Alzheimer’s disease via a personalized mathematical model
Sign Up to like & getrecommendations! Published in 2022 at "PLoS Computational Biology"
DOI: 10.1371/journal.pcbi.1010481
Abstract: With the recent approval by the FDA of the first disease-modifying drug for Alzheimer’s Disease (AD), personalized medicine will be increasingly important for appropriate management and counseling of patients with AD and those at risk.… read more here.
Keywords: beta therapy; amyloid beta; disease; anti amyloid ... See more keywords